International Journal of Cancer and Oncology

Safety and Efficacy of Continuous Low-dose Doxorubicin and Fluorouracil (5FU) with Best Supportive Care Compared to Best Standard of Care alone for Patients with Advanced Hepatocellular Carcinoma

– Bader Abdelmaksoud
Bader A. Abdelmaksoud*, Mostafa M. Toam, Alaa A. Fayed